ライフサイエンスコーパス: Leishmania braziliensis

1 a for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.

2 hway were abundant in skin lesions caused by Leishmania braziliensis.

3 atment for cutaneous leishmaniasis caused by Leishmania braziliensis.

4 Trypanosoma brucei and to a lesser extent in Leishmania braziliensis.

5 ecies of Leishmania: Leishmania infantum and Leishmania braziliensis.

6 marker of risk for CL development caused by Leishmania braziliensis.

7 s for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.

8 isplaying active ulcers and positive PCR for Leishmania braziliensis.

9 eishmania donovani, Leishmania infantum, and Leishmania braziliensis, a capacity to generate intra- a

10 Patients coinfected with Leishmania braziliensis and helminths took longer to hea

11 d associated with drug-treatment failures in Leishmania braziliensis and Leishmania guyanensis infect

12 .5%) of small RNAs derived from LRV1 in both Leishmania braziliensis and Leishmania guyanensis, mappi

13 iparasitic results against Trypnosoma cruzi, Leishmania braziliensis and Leishmania infantum were not

14 g more than 300 telomere-derived clones from Leishmania braziliensis and Leishmania major, a conserve

15 Dogs from an area of Leishmania braziliensis and Leishmania peruviana endemic

16 via through a joint evolutionary analysis of Leishmania braziliensis and their dsRNA Leishmania virus

17 teins from Lutzomyia intermedia, a vector of Leishmania braziliensis, and evaluated the seroreactivit

18 patients with cutaneous leishmaniasis due to Leishmania braziliensis are CD4(+)CD25(-)CD127(-/low)FOX

19 Leishmania braziliensis are intracellular parasites that

20 clinical (SC) or asymptomatic infection with Leishmania braziliensis are largely unknown.

21 s for the care of patients with CL caused by Leishmania braziliensis, because screening for and treat

22 Leishmania major and Leishmania braziliensis both cause cutaneous leishmanias

23 The control of Leishmania braziliensis by individuals with subclinical

24 and found that human patients infected with Leishmania braziliensis develop dysbiotic skin microbiot

25 We present the first covalent inhibitors of Leishmania braziliensis dihydroorotate dehydrogenase (Lb

26 Skin lesions from patients infected with Leishmania braziliensis has been associated with inflamm

27 nt of cutaneous leishmaniasis (CL) caused by Leishmania braziliensis in Brazil with pentavalent antim

28 ue, genome-wide transcriptional profiling of Leishmania braziliensis-infected cutaneous lesions and n

29 ripheral blood mononuclear cells (PBMC) from Leishmania braziliensis-infected human patients have dem

30 y, reducing Tregs in S. aureus-colonized and Leishmania braziliensis-infected mice increased IFN-gamm

31 de evidence of an IL-4-mediated pathology in Leishmania braziliensis-infected pregnant women.

32 We have previously reported that Leishmania braziliensis infection can activate murine de

33 Cutaneous leishmaniasis due to Leishmania braziliensis infection is an inflammatory dis

34 ross-protection against Leishmania major and Leishmania braziliensis infection.

35 Leishmania braziliensis infections are often associated

36 Leishmania braziliensis is a parasitic infection that ca

37 with cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is associated with high levels o

38 Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is characterized by a single ulc

39 Cutaneous leishmaniasis (CL) caused by Leishmania braziliensis is characterized by a strong Th1

40 al leishmaniasis, caused in South America by Leishmania braziliensis, is difficult to cure by chemoth

41 urrently, TriTrypDB integrates datasets from Leishmania braziliensis, L. infantum, L. major, L. taren

42 eened in vitro against Leishmania infantum , Leishmania braziliensis , Leishmania guyanensis , Leishm

43 dministration approved to treat CL caused by Leishmania braziliensis, Leishmania guyanensis, and Leis

44 the three complexes of New World Leishmania (Leishmania braziliensis, Leishmania mexicana, and Leishm

45 Leishmania braziliensis M2903 contains a highly amplifie

46 ntly enhanced infection with doses of >10(4) Leishmania braziliensis parasites in BALB/c mice.

47 asis, a neglected tropical disease caused by Leishmania braziliensis, presents treatment challenges d

48 the evolutionary history of parasites of the Leishmania braziliensis species complex based on whole-g

49 udy on the history of diversification of the Leishmania braziliensis species complex in Peru.

50 ified between 1992 and 1998 in an area where Leishmania braziliensis transmission is endemic; 8 of th